The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic hepatitis B infection, giving patients hope for a cure in the future. Professor Yuen Man-fung, chief of the division of gastroenterology and hepatology at HKU’s medical faculty, said on Thursday that existing medication for hepatitis B patients could only suppress the virus and had to be taken for decades. He expected that the new treatment could enable patients to discontinue...